These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9331174)

  • 1. Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease.
    Kordower JH; Chen EY; Winkler C; Fricker R; Charles V; Messing A; Mufson EJ; Wong SC; Rosenstein JM; Björklund A; Emerich DF; Hammang J; Carpenter MK
    J Comp Neurol; 1997 Oct; 387(1):96-113. PubMed ID: 9331174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice.
    Carpenter MK; Winkler C; Fricker R; Emerich DF; Wong SC; Greco C; Chen EY; Chu Y; Kordower JH; Messing A; Björklund A; Hammang JP
    Exp Neurol; 1997 Nov; 148(1):187-204. PubMed ID: 9398461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
    McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
    J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.
    Kordower JH; Winn SR; Liu YT; Mufson EJ; Sladek JR; Hammang JP; Baetge EE; Emerich DF
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10898-902. PubMed ID: 7971980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
    Emerich DF; Bruhn S; Chu Y; Kordower JH
    Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum.
    Emerich DF; Hammang JP; Baetge EE; Winn SR
    Exp Neurol; 1994 Nov; 130(1):141-50. PubMed ID: 7821389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
    Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
    Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
    Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.
    Pérez-Navarro E; Canudas AM; Akerund P; Alberch J; Arenas E
    J Neurochem; 2000 Nov; 75(5):2190-9. PubMed ID: 11183872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons.
    Kordower JH; Chen EY; Mufson EJ; Winn SR; Emerich DF
    Neuroscience; 1996 May; 72(1):63-77. PubMed ID: 8730706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
    Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
    Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
    Araujo DM; Hilt DC
    Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats.
    Date I; Ohmoto T; Imaoka T; Ono T; Hammang JP; Francis J; Greco C; Emerich DF
    J Neurosurg; 1996 Jun; 84(6):1006-12. PubMed ID: 8847564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
    Vazey EM; Chen K; Hughes SM; Connor B
    Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention.
    Watts C; Dunnett SB
    J Neurosurg; 1998 Aug; 89(2):267-74. PubMed ID: 9688122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo.
    Wehner T; Böntert M; Eyüpoglu I; Prass K; Prinz M; Klett FF; Heinze M; Bechmann I; Nitsch R; Kirchhoff F; Kettenmann H; Dirnagl U; Priller J
    J Neurosci; 2003 Jun; 23(12):5004-11. PubMed ID: 12832523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal stem cells can improve the motor function of a Huntington's disease rat model.
    Jiang Y; Lv H; Huang S; Tan H; Zhang Y; Li H
    Neurol Res; 2011 Apr; 33(3):331-7. PubMed ID: 21513650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
    Chen GJ; Jeng CH; Lin SZ; Tsai SH; Wang Y; Chiang YH
    J Biomed Sci; 2002; 9(4):303-10. PubMed ID: 12145527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA.
    Venero JL; Beck KD; Hefti F
    Neuroscience; 1994 Jul; 61(2):257-68. PubMed ID: 7969907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.
    Emerich DF; Lindner MD; Winn SR; Chen EY; Frydel BR; Kordower JH
    J Neurosci; 1996 Aug; 16(16):5168-81. PubMed ID: 8756445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.